Alzheimer's & Dementia: The Journal of the Alzheimer's Association
Volume 5, Issue 6 , Pages 454-462 , November 2009

Cerebral blood flow in ischemic vascular dementia and Alzheimer's disease, measured by arterial spin-labeling magnetic resonance imaging

  • Norbert Schuff

      Affiliations

    • Department of Veterans Affairs Medical Center, University of California at San Francisco, San Francisco, CA, USA
    • Department of Radiology, University of California at San Francisco, San Francisco, CA, USA
    • Corresponding Author InformationCorresponding author. Tel.: 415-221-4810, extension 4904; Fax: 415-668-2864.
    • ,
  • Shinji Matsumoto

      Affiliations

    • Federal Patent Office of Japan, Tokyo, Japan
    • ,
  • Joseph Kmiecik

      Affiliations

    • Department of Radiology, University of California at San Francisco, San Francisco, CA, USA
    • ,
  • Colin Studholme

      Affiliations

    • Department of Veterans Affairs Medical Center, University of California at San Francisco, San Francisco, CA, USA
    • Department of Radiology, University of California at San Francisco, San Francisco, CA, USA
    • ,
  • Antao Du

      Affiliations

    • Department of Veterans Affairs Medical Center, University of California at San Francisco, San Francisco, CA, USA
    • ,
  • Frank Ezekiel

      Affiliations

    • Department of Veterans Affairs Medical Center, University of California at San Francisco, San Francisco, CA, USA
    • Department of Radiology, University of California at San Francisco, San Francisco, CA, USA
    • ,
  • Bruce L. Miller

      Affiliations

    • Department of Neurology, University of California at San Francisco, San Francisco, CA, USA
    • ,
  • Joel H. Kramer

      Affiliations

    • Department of Psychiatry, University of California at San Francisco, San Francisco, CA, USA
    • ,
  • William J. Jagust

      Affiliations

    • School of Public Health and Helen Wills Neuroscience Institute, University of California at Berkeley, Berkeley, CA, USA
    • ,
  • Helen C. Chui

      Affiliations

    • Department of Neurology, University of Southern California, Los Angeles, CA, USA
    • ,
  • Michael W. Weiner

      Affiliations

    • Department of Veterans Affairs Medical Center, University of California at San Francisco, San Francisco, CA, USA
    • Department of Radiology, University of California at San Francisco, San Francisco, CA, USA
    • Department of Medicine, University of California at San Francisco, San Francisco, CA, USA

References 

  1. Tatemichi TK, Desmond DW, Prohovnik I. Strategic infarcts in vascular dementia. A clinical and brain imaging experience. Arzneimittelforschung. 1995;45:371–385
  2. Jellinger KA. The pathology of “vascular dementia”: a critical update. J Alzheimers Dis. 2008;14:107–123
  3. Pakrasi S, O'Brien JT. Emission tomography in dementia. Nucl Med Commun. 2005;26:189–196
  4. Jagust WJ, Budinger TF, Reed BR. The diagnosis of dementia with single photon emission computed tomography. Arch Neurol. 1987;44:258–262
  5. Messa C, Perani D, Lucignani G, Zenorini A, Zito F, Rizzo G, et al. High-resolution technetium-99m-HMPAO SPECT in patients with probable Alzheimer's disease: comparison with fluorine-18-FDG PET. J Nucl Med. 1994;35:210–216
  6. Herholz K, Schopphoff H, Schmidt M, Mielke R, Eschner W, Scheidhauer K, et al. Direct comparison of spatially normalized PET and SPECT scans in Alzheimer's disease. J Nucl Med. 2002;43:21–26
  7. Jagust W, Gitcho A, Sun F, Kuczynski B, Mungas D, Haan M. Brain imaging evidence of preclinical Alzheimer's disease in normal aging. Ann Neurol. 2006;59:673–681
  8. Deutsch G, Tweedy JR. Cerebral blood flow in severity-matched Alzheimer and multi-infarct patients. Neurology. 1987;37:431–438
  9. Tohgi H, Yonezawa H, Takahashi S, Sato N, Kato E, Kudo M, et al. Cerebral blood flow and oxygen metabolism in senile dementia of Alzheimer's type and vascular dementia with deep white matter changes. Neuroradiology. 1998;40:131–137
  10. Nagata K, Maruya H, Yuya H, Terashi H, Mito Y, Kato H, et al. Can PET data differentiate Alzheimer's disease from vascular dementia?. Ann NY Acad Sci. 2000;903:252–261
  11. Hanyu H, Shimuzu S, Tanaka Y, Takasaki M, Koizumi K, Abe K. Cerebral blood flow patterns in Binswanger's disease: a SPECT study using three-dimensional stereotactic surface projections. J Neurol Sci. 2004;220:79–84
  12. Shim YS, Yang DW, Kim BS, Shon YM, Chung YA. Comparison of regional cerebral blood flow in two subsets of subcortical ischemic vascular dementia: statistical parametric mapping analysis of SPECT. J Neurol Sci. 2006;250:85–91
  13. Muller TJ, Thome J, Chiaramonti R, Dierks T, Maurer K, Fallgatter AJ, et al. A comparison of QEEG and HMPAO-SPECT in relation to the clinical severity of Alzheimer's disease. Eur Arch Psychiatry Clin Neurosci. 1997;247:259–263
  14. Yang DW, Kim BS, Park JK, Kim SY, Kim EN, Sohn HS. Analysis of cerebral blood flow of subcortical vascular dementia with single photon emission computed tomography: adaptation of statistical parametric mapping. J Neurol Sci. 2002;203–204:199–205
  15. Fein G, Di S, V , Tanabe J, Cardenas V, Weiner MW, et al Hippocampal and cortical atrophy predict dementia in subcortical ischemic vascular disease. Neurology. 2000;55:1626–1635
  16. Mori E. Impact of subcortical ischemic lesions on behavior and cognition. Ann NY Acad Sci. 2002;977:141–148
  17. Tullberg M, Fletcher E, Decarli C, Mungas D, Reed BR, Harvey DJ, et al. White matter lesions impair frontal lobe function regardless of their location. Neurology. 2004;63:246–253
  18. Sabri O, Ringelstein EB, Hellwig D, Schneider R, Schreckenberger M, Kaiser HJ, et al. Neuropsychological impairment correlates with hypoperfusion and hypometabolism but not with severity of white matter lesions on MRI in patients with cerebral microangiopathy. Stroke. 1999;30:556–566
  19. Ott BR, Faberman RS, Noto RB, Rogg JM, Hough TJ, Tung GA, et al. A SPECT imaging study of MRI white matter hyperintensity in patients with degenerative dementia. Dement Geriatr Cogn Disord. 1997;8:348–354
  20. O'Sullivan M, Lythgoe DJ, Pereira AC, Summers PE, Jarosz JM, Williams SC, et al. Patterns of cerebral blood flow reduction in patients with ischemic leukoaraiosis. Neurology. 2002;59:321–326
  21. Chui HC. Dementia due to subcortical ischemic vascular disease. Clin Cornerstone. 2001;3:40–51
  22. Mungas D, Jagust WJ, Reed BR, Kramer JH, Weiner MW, Schuff N, et al. Quantitative MRI predictors of cognitive decline associated with Alzheimer's disease and cerebrovascular disease. Neurology. 2001;57:2229–2235
  23. Wong EC, Buxton RB, Frank LR. Quantitative perfusion imaging using arterial spin labeling. Neuroimag Clin North Am. 1999;9:333–342
  24. Alsop DC, Detre JA, Grossman M. Assessment of cerebral blood flow in Alzheimer's disease by spin-labeled magnetic resonance imaging. Ann Neurol. 2000;47:93–100
  25. Johnson NA, Jahng GH, Weiner MW, Miller BL, Chui HC, Jagust WJ, et al. Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience. Radiology. 2005;234:851–859
  26. Du AT, Jahng GH, Hayasaka S, Kramer JH, Rosen HJ, Gorno-Tempini ML, et al. Hypoperfusion in frontotemporal dementia and Alzheimer disease by arterial spin labeling MRI. Neurology. 2006;67:1215–1220
  27. Chui HC, Zarow C, Mack WJ, Ellis WG, Zheng L, Jagust WJ, et al. Cognitive impact of subcortical vascular and Alzheimer's disease pathology. Ann Neurol. 2006;60:677–687
  28. Chui HC, Victoroff JI, Margolin D, Jagust W, Shankle R, Katzman R. Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers. Neurology. 1992;42:473–480
  29. Chui H, Young L. Clinical criteria for various dementia subtypes: Alzheimer's disease (AD), vascular dementia (VaD), dementia with Lewy bodies (DLB), and frontotemporal dementia (FTD). In:  Broadaty H,  Chiu H,  Kaye J,  Qizilbash N editor. Evidence based Dementia. Oxford: Blackwell Science, Ltd; 2002;p. 106–117
  30. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34:939–944
  31. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994;
  32. Weiskopf RB, Kramer JH, Viele M, Neumann M, Feiner JR, Watson JJ, et al. Acute severe isovolemic anemia impairs cognitive function and memory in humans. Anesthesiology. 2000;92:1646–1652
  33. Reed BR, Eberling JL, Mungas D, Weiner M, Jagust WJ. Frontal lobe hypometabolism predicts cognitive decline in patients with lacunar infarcts. Arch Neurol. 2001;58:493–497
  34. Wong EC, Buxton RB, Frank LR. Quantitative imaging of perfusion using a single subtraction (QUIPSS and QUIPSS II). Magn Reson Med. 1998;39:702–708
  35. Edelman RR, Chen Q, Epistar MRI. multislice mapping of cerebral blood flow. Magn Reson Med. 1998;40:800–805
  36. Tanabe JL, Amend D, Schuff N, DiSclafani V, Ezekiel F, Norman D, et al. Tissue segmentation of the brain in Alzheimer disease. AJNR. 1997;18:115–123
  37. Iordanova B, Rosenbaum D, Norman D, Weiner M, Studholme C. MR imaging anatomy in neurodegeneration: a robust volumetric parcellation method of the frontal lobe gyri with quantitative validation in patients with dementia. AJNR. 2006;27:1747–1754
  38. Ye FQ, Mattay VS, Jezzard P, Frank JA, Weinberger DR, McLaughlin AC. Correction for vascular artifacts in cerebral blood flow values measured by using arterial spin tagging techniques. Magn Reson Med. 1997;37:226–235
  39. Studholme C, Hill DL, Hawkes DJ. Automated three-dimensional registration of magnetic resonance and positron emission tomography brain images by multiresolution optimization of voxel similarity measures. Med Phys. 1997;24:25–35
  40. Schuff N, Ezekiel F, Gamst AC, Amend DL, Capizzano AA, Maudsley AA, et al. Region and tissue differences of metabolites in normally aged brain using multislice 1H magnetic resonance spectroscopic imaging. Magn Reson Med. 2001;45:899–907
  41. Mardia KV, Kent JT, Bibby JM. Multivariate Analysis. New York: Academic Press; 1979;
  42. Yang J, Huang S, Mega M, Lin K, Toga A, Small G, et al. Investigation of partial volume correction methods for brain FDG PET studies. IEEE Trans Nucl Sci. 1996;43:3322–3327
  43. Matsuda H, Kanetaka H, Ohnishi T, Asada T, Imabayashi E, Nakano S, et al. Brain SPECT abnormalities in Alzheimer's disease before and after atrophy correction. Eur J Nucl Med Mol Imag. 2002;29:1502–1505
  44. Schuff N, Capizzano AA, Du AT, Amend DL, O'Neill J, Norman D, et al. Different patterns of N-acetylaspartate loss in subcortical ischemic vascular dementia and AD. Neurology. 2003;61:358–364
  45. Tohgi H, Yonezawa H, Takahashi S, Sato N, Kato E, Kudo M, et al. Cerebral blood flow and oxygen metabolism in senile dementia of Alzheimer's type and vascular dementia with deep white matter changes. Neuroradiology. 1998;40:131–137
  46. Hirono N, Mori E, Ishii K, Ikejiri Y, Imamura T, Shimomura T, et al. Frontal lobe hypometabolism and depression in Alzheimer's disease. Neurology. 1998;50:380–383
  47. Vinters HV, Ellis WG, Zarow C, Zaias BW, Jagust WJ, Mack WJ, et al. Neuropathologic substrates of ischemic vascular dementia. J Neuropathol Exp Neurol. 2000;59:931–945
  48. Kraut MA, Beason-Held LL, Elkins WD, Resnick SM. The impact of magnetic resonance imaging-detected white matter hyperintensities on longitudinal changes in regional cerebral blood flow. J Cereb Blood Flow Metab. 2008;28:190–197
  49. Gunther M, Oshio K, Feinberg DA. Single-shot 3D imaging techniques improve arterial spin labeling perfusion measurements. Magn Reson Med. 2005;54:491–498

PII: S1552-5260(09)00101-0

doi: 10.1016/j.jalz.2009.04.1233

Alzheimer's & Dementia: The Journal of the Alzheimer's Association
Volume 5, Issue 6 , Pages 454-462 , November 2009

Article Tools

* Image Usage & Resolution